Former French Ambassador to Asharq Al-Awsat: Washington Accused Us of Lying about WMD in Iraq

Former Ambassador Maurice Gourdault-Montagne with late French President Jacques Chirac (Getty)
Former Ambassador Maurice Gourdault-Montagne with late French President Jacques Chirac (Getty)
TT

Former French Ambassador to Asharq Al-Awsat: Washington Accused Us of Lying about WMD in Iraq

Former Ambassador Maurice Gourdault-Montagne with late French President Jacques Chirac (Getty)
Former Ambassador Maurice Gourdault-Montagne with late French President Jacques Chirac (Getty)

Former French Ambassador Maurice Gourdault-Montagne, who recently published a remarkable book entitled "The Others Don't Think Like Us," experienced the US invasion of Iraq "first hand."

Gourdault-Montagne served as the diplomatic adviser to late French President Jacques Chirac and his representative at the G7 and G20 in the summer of 2002 and until the end of Chirac's second term.

The diplomat participated in all presidential meetings that preceded the US military operation in Iraq. Paris tried to dissuade Washington from its military "adventure," asserting that the UN Security Council must back any military intervention.

On the occasion of the 20th anniversary of the Iraq war, Asharq Al-Awsat interviewed Gourdault-Montagne, revealing many of the meetings he attended in Washington and worldwide, which led to two contradictory visions.

The first, backed by the US administration under President George W. Bush, wanted war at any cost. The second centered around France, which hinted at resorting to its veto right against any US draft resolution.

The ambassador also recounted the details of several summits he attended alongside Chirac, namely the NATO summit in Prague in 2002, which revealed Bush's desire to overthrow the regime of President Saddam Hussein, claiming he possessed weapons of mass destruction (WMD).

Asharq Al-Awsat asked the diplomat about the last chapter of his book, which detailed the confrontation between Chirac and Bush during the Prague Summit.

Gourdault-Montagne recalled that the summit occurred when the Middle East was on the verge of war. Chirac sought to discourage Bush from embarking on an adventure with miscalculated results.

During the meeting, Bush did not even look at Chirac, said the former official, adding that what the French President said can be summed up as follows: a war against Iraq would destabilize the region, bringing Iran-loyalist Shiites to power in Baghdad and strengthening Tehran's influence in Syria and Lebanon through Hezbollah.

Chirac told Bush that his war didn't have legal grounds and would create division within the international community, warning that it would be a source of chaos leading to terrorism.

Gourdault-Montagne said that, even before Prague, France was convinced that Washington was going to war at any cost. He recalled Bush's famous speech at the West Point military base, where he spoke of the "Axis of Evil," which included Iraq.

Washington believed at the time that the Middle East was necessary for global balance, and it was essential to impose a "new Middle East" as it envisioned. However, things did not go according to their vision.

He noted that the US might have successfully formed a coalition of 49 countries to intervene in Iraq. Still, major countries led by France, Russia, and China rejected their plans.

"We adhered to a clear position, which states that there is no legitimacy for military action in Iraq without a Security Council resolution."

Chirac believed that Saddam's acceptance of the inspection meant that he lost part of his authority, which would collapse due to the structure of his regime, meaning there was no need to rush into a military operation that lacked legitimacy.

Gourdault-Montagne also recalled the widespread rejection of the war and the worldwide demonstrations against it.

Asharq Al-Awsat asked the diplomat about his analysis of Bush and Chirac's meeting. He indicated that it was clear Bush was refusing dialogue, and the French delegation came out of the meeting convinced that the US was proceeding with its plan.

He noted that the US accused France of lying, adding that the Deputy Secretary of Defense Paul Wolfowitz told him, "we know that you know" that Iraq possessed WMD, but "you want to cover up and protect the regime."

The US pressured France, seeking to legitimize the military intervention, said Gourdault-Montagne, adding that Paris resisted, which led to the differences between the two countries.

At the beginning of 2013, Chirac asked Gourdault-Montagne to travel to Washington to clarify the situation and inquire about the latest US position.

The French diplomat asked Bush's National Security Adviser, Condoleezza Rice, about their demands to abandon the war.

"What are your conditions?" he said, and Rice replied firmly: "For Saddam to step down."

Paris then realized that Washington wanted a regime change, and the issue of weapons of mass destruction was just an excuse.

The US administration did not notify France of the launch date of the military operation, for which preparations were in full swing, according to Gourdault-Montagne.

At the beginning of March, Chirac held a press conference warning that the war was coming and that France did its best to prevent it but failed.

Regarding weapons of mass destruction, Asharq Al-Awsat asked if it was just an excuse or whether the US had evidence.

He asserted that France did not receive any information confirming Washington's claims. He indicated that US Secretary of State Colin Powell is a respectable man and was sincere in his speech at the Security Council, during which he gave false information about the war.

Gourdault-Montagne believed that Powell thought the information he received from the intelligence services was reliable and accurate. In 2008, Powell expressed disappointment and shame at what he said.

After 20 years, France was right in trying to prevent the war, and although it failed, it did not violate international laws, said the diplomat.

The war led to the emergence of new powers, the so-called "emerging" countries, and created imbalances in the existing alliances, as NATO member states, such as France and Germany, refused to support the US.

Asked about the US mistakes after occupying Iraq, including the disbanding of the Iraqi army at the hands of the US envoy and Iraq's ruler, Paul Bremer, the French diplomat noted that Saddam's regime was a dictatorship that ruled Iraq with an iron fist.

The decision of Bremer, who lacked experience, had consequences after soldiers took up arms in their communities, according to Gourdault-Montagne, who said that weapons with complex problems could lead to civil wars.

Addressing current events, Gourdault-Montagne believes the next two years will be challenging amid the US-Chinese competition. He referred to the presidential elections in Taiwan at the beginning of 2024 and the US elections in November 2024.

He also indicated that Washington would seek to drag the Europeans and NATO into a confrontation with China, and Beijing would seek to mobilize its trade and economic partners.

Last June, the final statement of the NATO summit warned that China poses a "systemic challenge to the Euro-Atlantic region," and Gourdault-Montagne cautioned that it could drag the Alliance into a US-Chinese competition, despite the opposition of some European countries, including France and Germany.

The visit of German Chancellor Olaf Scholz to Beijing and that of the French President next month are essential because they present views different than that of the US, said Gourdault-Montagne.

He concluded that the US plan was based on framing global security around NATO.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.